Skip to content

Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

MindBio Therapeutics Corp. is advancing real-time intoxication detection by leveraging artificial intelligence (AI) and voice analysis to identify impairment from brief speech recordings. This innovative approach aims to address the challenges posed by traditional detection methods and is part of a broader trend towards noninvasive diagnostics in health and AI. The growing demand for effective intoxication assessment highlights the societal burden of substance abuse, which contributes to millions of deaths annually and significant workplace risks.

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods is intensifying. MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) (profile) is taking a distinctive approach: harnessing artificial intelligence (AI) and voice analysis to predict impairment from brief speech recordings. By treating the human voice as a window into underlying physiological and cognitive states, MindBio is focused on building a platform capable of detecting intoxication across a wide variety of substances in real-time. This approach addresses a meaningful gap in existing detection technology and reflects a larger move toward AI-powered, noninvasive diagnostics with the potential to reshape how enforcement, employers and health systems identify and respond to impairment. MindBio is part of a broader group of companies working at the crossroads of health and AI, including Spectral AI Inc. (NASDAQ: MDAI), Nano-X Imaging Ltd. (NASDAQ: NNOX), NVIDIA Corporation (NASDAQ: NVDA) and Caris Life Sciences Inc. (NASDAQ: CAI).